Medicine & Life Sciences
rucaparib
88%
Poly(ADP-ribose) Polymerases
58%
Gene Fusion
55%
Prostatic Neoplasms
38%
Radiation
36%
Poly(ADP-ribose) Polymerase Inhibitors
32%
DNA Damage
21%
Brachytherapy
17%
8-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-one
15%
Survival
13%
Galactosidases
12%
PC-3 Cells
10%
DNA Breaks
10%
Radiation Tolerance
9%
Homologous Recombination
9%
DNA Repair
7%
Radiotherapy
5%
Staining and Labeling
5%
Cell Line
4%
Mutation
4%
DNA
4%
Proteins
3%
Neoplasms
2%
Therapeutics
1%
Agriculture & Biology
NAD ADP-ribosyltransferase
72%
prostatic neoplasms
66%
gene fusion
58%
neoplasm cells
44%
brachytherapy
32%
DNA damage
28%
dosage
25%
galactosidases
13%
cells
12%
homologous recombination
11%
DNA repair
10%
DNA
9%
lethal genes
9%
irradiation
7%
neoplasms
7%
cell lines
7%
staining
7%
mutation
6%
toxicity
6%
proteins
3%
Chemical Compounds
Rucaparib
100%
Poly(ADPribose)
66%
Clonogenic
37%
Lethal
9%
Genotoxic
9%
Mutation
6%
Protein
3%
Time
2%